Η Ομάδα Μας

Victoria holds a Ph.D. in Neuroscience from the University of Cambridge and a BSc in Biochemistry and Microbiology from King's College London, from which she has an Associate Degree in Philosophy as well. She started her career as a Postdoctoral Fellow at the Neuroendocrinology Lab in Rockefeller University, New York, and had affiliations as a Research Fellow with Universities of Athens (Neurosurgery) and Patras (Engineering) before making a career shift to business. Most of her career is in the Technology Sector and she has significant leadership experience across technology and commercial roles with both multinationals such as Microsoft as well as start-up/scale-up companies. She is a founder of Insaitu, a company deeply rooted in innovation working on 'augmented intelligence technologies' in the fields of applied neuroscience, healthcare, and sustainability. Since 2018, she is a fellow of the University of Cambridge Judge Business School where she supports initiatives, innovators, and companies that primarily focus on addressing challenges with global impact.

"The Real Genius of Technology is People" With >25 years’ experience in health care management and consultancy, Greg has undertaken a wide range of assignments in the public and private health care sectors in the US, Europe, MENA, Baltics, LATAM & APAC. Experienced in strategic planning, marketing and communication, with a strong track record in managing stakeholders, payers and doctors. An expert in the establishment and development of primary care centers and the design of architected sales solutions for hospital networks; pivotal in the strategic planning of healthcare marketing strategies and services integration to private and public HMOs. Greg has pioneered the establishment and development of biobanking and cell therapy preclinical services in the EU - MENA region. He contributed and managed the creation and development of Genoma; a Swiss company in proteomics and genomics for predictive medicine with the first genetic platform for clinical diagnostics in Europe utilizing the latest NGS technologies. Over the past 10 years further paved his career into precision medicine initiatives, digital and connected health. Relocated to the US and served as the Director of Global Strategic Partnerships at Veritas Genetics, The Genome Company. With a focus on bringing advanced personalized cell and gene therapies (CGTs) therapies to market effectively, he strategized the set up, validation and deployment of a unique global point-of-care manufacturing platform. Currently serving as Senior Strategy Advisor @NanoNeurosciences, Inc., a preclinical start-up, with a patented, first-in-class, cutting edge nanotheurapeutics for regenerative medicine. Next challenge, integration of CGT - ATMPs with AI & genomics. Professional Affiliations - Participations ▪BioInnovation Greece, Associate Partner, (2025-Present) ▪European Association of Hospital Managers, Executive Committee Member, (2006-2015) ▪ITERA (International Tissue Engineering Research Association) Life – Sciences Forum, Officer, (2007- Present) ▪Post Graduate Health Management Programme, Conservatoire National Des Arts Et Metiers, Lecturer, (2003-Present) Has been Member of Organizing & Scientific committees of numerous health management congresses, and publishes regularly articles on health management issues.

Ioanna is an attorney specializing in Life Sciences and Medical Technology law and Managing Partner at Michalopoulou & Associates-Lawgroup. With over two decades of expertise, she has distinguished herself as one of Greece's foremost legal experts, serving a global clientele across Europe, the Middle East, and Africa. Her practice is devoted to addressing intricate legal challenges faced by leading Healthcare, Pharmaceutical, Medical Device and Food industry organizations. Renowned for her mastery in navigating complex regulatory landscapes, Ioanna and her team excel in areas such as healthcare compliance, competition law, mergers and acquisitions, intellectual property, and data protection. Her expertise in the EU Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) underscores her commitment to staying at the forefront of regulatory advancements. Ioanna holds an LL.M. from the Université Catholique de Louvain and is a graduate of the University of Athens Law School. As a speaker, she frequently presents at international conferences on topics including compliance, artificial intelligence in healthcare, big data, and the intersection of personal data regulations with innovative fields such as orphan drugs, gene therapies, and advanced medical devices.